This bill asks state agencies and law enforcement groups to report on how they are using opioid settlement funds for treatment and prevention programs in correctional facilities. It also requests that the Opioid Abatement Task Force and the Attorney General provide clearer guidance on which expenses are allowed under these funds. The measure aims to address concerns raised in a recent audit that many local areas have not spent their allocated money due to confusion about rules and a lack of available programs. By gathering this information, the state hopes to ensure that the millions of dollars received from opioid lawsuits are used effectively to help incarcerated individuals with substance use disorders.
This bill updates Louisiana laws to clarify the role of the Department of Health in managing rural summer meal distribution sites. It specifically defines these locations as places that only distribute pre-packaged, shelf-stable food without preparing meals on-site. Under the new rules, the state health officer will have the authority to create and enforce regulations for these specific sites, treating them differently from traditional food service establishments. The legislation aims to provide a clear legal framework for how these programs operate in rural areas.
HB 1199 mandates that health insurance plans cover genetic testing and treatments for SCN2A-associated medical conditions without imposing cost-sharing fees on members who are covered under their policy. The bill requires insurers to include these specific services in their coverage without charging patients a portion of the cost. This legislation directly affects individuals with SCN2A-related conditions and the health insurance providers who must adjust their benefit structures accordingly.
This Senate Resolution asks the Louisiana Department of Insurance and the Department of Health to jointly review how the state's biomarker testing coverage law is being enforced. The study will examine claims data from 2024 to the present to understand why some tests are denied, how long approval takes, and what barriers patients face. The agencies must submit a report by February 1, 2027, detailing their findings and offering recommendations to improve patient access to these medical tests. This bill does not change any laws but instead directs government officials to investigate current practices and report back to the legislature.
This bill allows licensed physicians in Louisiana to use nitrous oxide as pain relief during minor office surgeries and similar procedures. It requires the Louisiana State Board of Medical Examiners to create specific safety guidelines for this practice while explicitly prohibiting the board from banning its use in these settings. The legislation directly affects doctors who may now have an additional tool for managing patient pain in outpatient settings, provided they follow the board's rules.
This bill asks the Louisiana Department of Health to raise the monthly Medicaid reimbursement rate for breast pumps and related supplies from $80 to at least $140. The change is intended to encourage more providers to participate in the program and ensure that mothers have better access to quality equipment, particularly those who work or face logistical challenges. By aligning the rate with the national average seen in other states, the resolution aims to support breastfeeding and potentially improve maternal and infant health outcomes. The Department of Health is urged to implement this increase through standard administrative processes while remaining compliant with federal Medicaid rules.
This bill, titled the Louisiana Clinical Trial Competitiveness and Patient Access Act, aims to support economic development by establishing a framework for clinical trials within the state. It directly affects healthcare providers, pharmaceutical companies, and patients by creating new provisions to enhance the competitiveness of clinical research in Louisiana. The legislation includes specific amendments that clarify the law does not override federal restrictions and expands the scope of protected protocols to include nonpublic ones. By adding these details, the bill seeks to provide clearer guidelines for conducting clinical trials while ensuring compliance with existing federal regulations.
This Senate Resolution requests the Louisiana Department of Health to create a task force dedicated to upgrading the state's cancer data system. The proposed group will study how to modernize the Louisiana Tumor Registry by improving electronic health record sharing and enabling real-time cancer tracking. The task force will consist of eleven members from healthcare, technology, and public health sectors who will develop recommendations for better data collection and infrastructure. Their work will focus on identifying gaps in cancer care access and creating a plan for sustainable expansion of the registry. The group is required to submit its findings and any proposed laws to the Senate by February 1, 2027.
This Louisiana legislative resolution designates Friday, May 22, 2026, as World Preeclampsia Awareness Day within the state. The measure aims to raise public awareness about preeclampsia, a dangerous pregnancy complication involving high blood pressure that poses risks to both mothers and infants. Additionally, the resolution acknowledges Woman's Hospital for its role in providing care to pregnant women and working to reduce maternal and infant deaths. The bill is a symbolic gesture intended to highlight the importance of addressing maternal health issues in Louisiana.
This bill modifies an existing law regarding pregnant women in custody to clarify that funding for their care can come from nonprofit organizations or federal grants. The change is a minor amendment that adds specific sources of financial support to the current legal framework. It directly affects state agencies responsible for managing the healthcare of incarcerated pregnant women. The legislation does not alter the core requirement for providing care but expands the list of permissible funding origins.
